10 at 10: These ASX stocks have suited up this morning
News
News
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.
The market opens at 10am (eastern time) and the data is taken at 10:15am, once every stock has commenced trading.
Stocks highlighted in yellow have made market-moving announcements (click headings to sort)
Code | Name | Price | % Chg | Volume |
---|---|---|---|---|
TKL | Traka Resources Ltd | 0.035 | +250.00% | 3.1M |
EN1 | engage:BDR Ltd | 0.012 | +50.00% | 58.9M |
MLS | Metals Australia Ltd | 0.002 | +33.33% | 8.0M |
CGS | Cogstate Ltd | 0.53 | +26.19% | 13.7k |
TPD | Talon Petroleum Ltd | 0.0025 | +25.00% | 21.6M |
ALT | Analytica Ltd | 0.0025 | +25.00% | 2.1M |
EFE | Eastern Iron Ltd | 0.006 | +20.00% | 7.0M |
LCY | Legacy Iron Ore Ltd | 0.006 | +20.00% | 7.8M |
RBR | RBR Group Ltd | 0.006 | +20.00% | 237.3k |
AGE | Alligator Energy Ltd | 0.006 | +20.00% | 550.0k |
Advertising technology company engage:BDR (ASX:EN1) unveiled a new client onboarding in Tappx, Europe’s second fastest growing advertising company.
In gold, Traka Resources (ASX:TKL) more than doubled after securing rights to the Mt Caittlin project. Also Metals Australia (ASX:MLS) declared that it had identified numerous exploration targets
Code | Name | Price | % Chg | Volume |
---|---|---|---|---|
VIC | Victory Mines Ltd | 0.0015 | -25.00% | 10.3M |
FPL | Fremont Petroleum Corp Ltd | 0.003 | -25.00% | 751.4k |
CZN | Corazon Mining Ltd | 0.004 | -20.00% | 9.5M |
AVW | Avira Resources Ltd | 0.005 | -16.67% | 300.0k |
CAN | Cann Group Ltd | 0.54 | -14.40% | 1.8M |
ADX | ADX Energy Ltd | 0.006 | -14.29% | 1.9M |
RHY | Rhythm Biosciences Ltd | 0.09 | -13.33% | 391.7k |
OEL | Otto Energy Ltd | 0.007 | -12.50% | 631.4k |
LCT | Living Cell Technologies Ltd | 0.015 | -11.76% | 416.4k |
DCX | Discovex Resources Ltd | 0.008 | -11.11% | 11.3M |
Aspiring colorectal cancer test maker Rhythm Bioscience (ASX:RHY) fell with news of a capital raising.